[go: up one dir, main page]

MX9703281A - Un sistema de suministro para agentes antimetanogenicos. - Google Patents

Un sistema de suministro para agentes antimetanogenicos.

Info

Publication number
MX9703281A
MX9703281A MX9703281A MX9703281A MX9703281A MX 9703281 A MX9703281 A MX 9703281A MX 9703281 A MX9703281 A MX 9703281A MX 9703281 A MX9703281 A MX 9703281A MX 9703281 A MX9703281 A MX 9703281A
Authority
MX
Mexico
Prior art keywords
antimethanogenic
agents
delivery system
agent
delivery
Prior art date
Application number
MX9703281A
Other languages
English (en)
Inventor
Christopher May
Alan Lindsay Payne
Philip Laurence Stewart
John Alexander Edgar
Original Assignee
Commw Scient Ind Res Org
Res Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org, Res Organization filed Critical Commw Scient Ind Res Org
Publication of MX9703281A publication Critical patent/MX9703281A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A23K40/35—Making capsules specially adapted for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
    • Y02P60/22—Methane [CH4], e.g. from rice paddies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a un sistema para el suministro de un agente antimetanogénico volátil y/o soluble en agua o un animal, una composicion que comprende el agente y los métodos de tratamiento que dan como resultado una ganancia mejorada del peso a un diámetro reducido de la fibra de lana.
MX9703281A 1994-11-04 1997-05-06 Un sistema de suministro para agentes antimetanogenicos. MX9703281A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM9225A AUPM922594A0 (en) 1994-11-04 1994-11-04 Reduction of methane production in animals

Publications (1)

Publication Number Publication Date
MX9703281A true MX9703281A (es) 1998-07-31

Family

ID=3783740

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703281A MX9703281A (es) 1994-11-04 1997-05-06 Un sistema de suministro para agentes antimetanogenicos.

Country Status (9)

Country Link
US (2) US5972910A (es)
EP (1) EP0782442B1 (es)
AU (1) AUPM922594A0 (es)
CA (1) CA2204358A1 (es)
DE (1) DE69532504T2 (es)
MX (1) MX9703281A (es)
NZ (1) NZ294788A (es)
WO (1) WO1996014062A1 (es)
ZA (1) ZA959313B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM922594A0 (en) * 1994-11-04 1994-11-24 Commonwealth Scientific And Industrial Research Organisation Reduction of methane production in animals
WO2001026482A1 (en) * 1999-10-14 2001-04-19 Dcv, Inc. Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals
US6743440B1 (en) 1999-10-14 2004-06-01 Arkion Life Sciences Llc Polycyclic quinone and ionophore composition for the synergistic reduction of methane formation in ruminant animals
US20090227005A1 (en) * 2007-03-27 2009-09-10 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods for pathogen detection
US8673219B2 (en) 2010-11-10 2014-03-18 Invention Science Fund I Nasal passage insertion device for treatment of ruminant exhalations
US11285360B2 (en) 2017-11-06 2022-03-29 Angus Lochhead Shoulder exercise machine
DK4037666T3 (da) 2020-12-08 2024-06-24 Ruminant Biotech Corp Ltd Forbedring af anordninger og fremgangsmåder til indgivelse af substanser til dyr
AU2021221810B2 (en) * 2020-12-08 2023-02-02 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals
AU2022100024C4 (en) * 2020-12-08 2024-12-12 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals
AU2023219615B2 (en) * 2022-02-09 2025-03-06 FutureFeed Pty Ltd Novel compositions for reducing methane production in ruminant animals
US12084610B2 (en) 2022-07-01 2024-09-10 Arkea Bio Corp. Compositions and methods for reducing deleterious atmospheric gas emissions from flooded ecosystems
AU2023237101A1 (en) 2022-09-29 2024-04-18 Ch4 Global, Inc. Seaweed feed products and methods for processing seaweed
AR130919A1 (es) 2022-11-02 2025-01-29 Ruminant Biotech Corp Ltd Dispositivos y métodos para administrar compuestos inhibidores de metano a los animales
CN120712022A (zh) 2022-12-21 2025-09-26 丹麦农业格夫萨博有限责任公司 用于减少反刍动物体内甲烷产生和/或改善反刍动物生产性能的方法
US12336553B2 (en) 2023-02-08 2025-06-24 Rumin8 Pty Ltd Compositions and methods for reducing greenhouse gas
WO2025029158A1 (en) * 2023-08-01 2025-02-06 Ruminant Biotech Corp Limited Improved bolus designs for administration to a ruminant animal and uses thereof
WO2025220006A1 (en) 2024-04-15 2025-10-23 Bromine Compounds Ltd. Stable solid compositions with high content of bromoform

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1315795A (en) * 1972-01-22 1973-05-02 Smith Kline French Lab Method and compositions for feed efficiency of ruminants
US5069936A (en) * 1987-06-25 1991-12-03 Yen Richard C K Manufacturing protein microspheres
AU7453191A (en) * 1990-03-02 1991-09-18 Australian Commercial Research & Development Limited Cyclodextrin compositions and methods for pharmaceutical and industrial applications
JPH06172189A (ja) * 1992-08-17 1994-06-21 Bristol Myers Squibb Co 胃腸保護複合剤
AU673057B2 (en) * 1993-02-22 1996-10-24 Abraxis Bioscience, Llc Methods for (in vivo) delivery of biologics and compositionsuseful therefor
AU692481B2 (en) * 1993-10-19 1998-06-11 Commonwealth Scientific And Industrial Research Organisation Method for improving utilisation of nutrients by ruminant or ruminant-like animals
AUPM922594A0 (en) * 1994-11-04 1994-11-24 Commonwealth Scientific And Industrial Research Organisation Reduction of methane production in animals

Also Published As

Publication number Publication date
EP0782442A4 (en) 2000-03-22
WO1996014062A1 (en) 1996-05-17
DE69532504T2 (de) 2004-12-23
ZA959313B (en) 1996-05-29
CA2204358A1 (en) 1996-05-17
US6251879B1 (en) 2001-06-26
US5972910A (en) 1999-10-26
DE69532504D1 (de) 2004-03-04
AUPM922594A0 (en) 1994-11-24
EP0782442B1 (en) 2004-01-28
EP0782442A1 (en) 1997-07-09
NZ294788A (en) 1999-01-28

Similar Documents

Publication Publication Date Title
MX9703281A (es) Un sistema de suministro para agentes antimetanogenicos.
AR002944A1 (es) Uso de una composicion de gel acuosa que contiene una o mas drogas que son eficaces para tratar hemorroides para la preparacion de un medicamento y dicha composicion de gel acuosa
ES2129980T3 (es) Sistema de afeitado en humedo con un material compuesto que favorece el afeitado, con un complejo de inclusion de un agente suavizante de la piel y ciclodextrina.
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
ES2105913T3 (es) Composiciones para el teñido de las fibras queratinicas que comprenden un orto-diamino pirazol y una sal de manganeso, procedimiento de teñido que utiliza estas composiciones.
ES2161210T3 (es) Composiciones anti-patogenamente eficaces que comprenden peptidos liticos y enzimas hidroliticas.
ES2176354T3 (es) Uso de nebivolol como agente anti-aterogenico.
ES2130217T3 (es) Uso de tiloxapol como dispersante y estabilizante de nanoparticulas.
BR9206632A (pt) Sistema de penetração na pele melhorado para melhorada liberação tópica de drogas
CR6656A (es) Forma de dosificacion de farmacos accionada por un hidrogel
ATE288744T1 (de) Arzneiformulierungen zur hormonersatztherapie zur topischen anwendung auf der haut
ES2164767T3 (es) Formulaciones de propionato de fluticasona.
ES2137372T3 (es) Solucion antifungica para las uñas.
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
ES2156839T1 (es) Medicamento que contiene alginato e implante para tratar la fibrosis.
PE90999A1 (es) Compuestos para coloracion del cabello y su utilizacion
GT199800126A (es) Terapia de combinacion.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
ES2040137T3 (es) Agente para la tincion del pelo y su empleo.
ES2032955T3 (es) Sal sodica anhidra cristalina de 5-cloro-3-(2-tenoil)-2-oxindol-1-carboxamida.
AR032151A1 (es) Uso de un farmaco anti-angiogenico en conjunto con un agente fotosensible para la preparacion de un medicamento para el tratamiento fotodinamico mejorado de la neovasculatura indeseada
ES2188995T3 (es) Uso de un inhibidor de la h+, k+-atpasa en el tratamiento de los polipos nasales.
ES2169223T3 (es) Substancia anticancerosa que inhibe la metastasis cancerosa.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees